PTX 2.50% 3.9¢ prescient therapeutics limited

Time to shine PTX, page-4

  1. 313 Posts.
    From latest Ann: "The company plans to initiate Phase 1b/2 clinical trial of PTX-100 in multiple myeloma in H1 2015.".
    But yes, you're correct, PTX-200 is currently in Phase 1b/2. But this is one drug, two trials.
    I'll also correct myself...its Co-X-gene technology.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
-0.001(2.50%)
Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.0¢ 3.9¢ $3.806K 96.37K

Buyers (Bids)

No. Vol. Price($)
5 172911 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 19248 1
View Market Depth
Last trade - 14.46pm 20/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.